Radiopharmaceutical MarketGlobal Radiopharmaceuticals Market Size, Share and Report Analysis By Type (Therapeutic radiopharmaceuticals, Diagnostic radiopharmaceuticals), By Application (Oncology, Cardiology, Neurology, Gastroenterology, Nephrology, Other), By Radioisotopes (Technetium‑99m (Tc‑99m), Fluorine‑18 (F‑18), Iodine‑131 (I‑131), Lutetium‑177 (Lu‑177), Gallium‑68 (Ga‑68), Yttrium‑90 (Y‑90), Other isotopes), By End-user (Hospitals, Diagnostic / imaging centers, Specialty / cancer centers, Academic & research institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Radiopharmaceuticals Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Radiopharmaceuticals Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Radiopharmaceuticals Market Analysis and Forecast, By Type
  • 6.1. Key Findings
  • 6.2. Global Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 6.2.1. Therapeutic radiopharmaceuticals
    • 6.2.2. Diagnostic radiopharmaceuticals
  • 6.3. Global Radiopharmaceuticals Market Attractiveness Analysis, By Type
• 7. Global Radiopharmaceuticals Market Analysis and Forecast, By Application
  • 7.1. Key Findings
  • 7.2. Global Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 7.2.1. Oncology
    • 7.2.2. Cardiology
    • 7.2.3. Neurology
    • 7.2.4. Gastroenterology
    • 7.2.5. Nephrology
    • 7.2.6. Other
  • 7.3. Global Radiopharmaceuticals Market Attractiveness Analysis, By Application
• 8. Global Radiopharmaceuticals Market Analysis and Forecast, By Radioisotopes
  • 8.1. Key Findings
  • 8.2. Global Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 8.2.1. Technetium‑99m (Tc‑99m)
    • 8.2.2. Fluorine‑18 (F‑18)
    • 8.2.3. Iodine‑131 (I‑131)
    • 8.2.4. Lutetium‑177 (Lu‑177)
    • 8.2.5. Gallium‑68 (Ga‑68)
    • 8.2.6. Yttrium‑90 (Y‑90)
    • 8.2.7. Other isotopes
  • 8.3. Global Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• 9. Global Radiopharmaceuticals Market Analysis and Forecast, By End-user
  • 9.1. Key Findings
  • 9.2. Global Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic / imaging centers
    • 9.2.3. Specialty / cancer centers
    • 9.2.4. Academic & research institutes
  • 9.3. Global Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• 10. Global Radiopharmaceuticals Market Analysis and Forecast, By Region
  • 10.1. Key Findings
  • 10.2. Global Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Middle East & Africa
    • 10.2.5. Latin America
  • 10.3. Global Radiopharmaceuticals Market Attractiveness Analysis, By Region
• 11. North America Radiopharmaceuticals Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. North America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
  • 11.3. North America Radiopharmaceuticals Market Attractiveness Analysis, By Type
  • 11.4. North America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
  • 11.5. North America Radiopharmaceuticals Market Attractiveness Analysis, By Application
  • 11.6. North America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
  • 11.7. North America Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
  • 11.8. North America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
  • 11.9. North America Radiopharmaceuticals Market Attractiveness Analysis, By End-user
  • 11.10. North America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 11.11. North America Radiopharmaceuticals Market Attractiveness Analysis, By Country
    • 11.11.1. The US Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 11.11.2. The US Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 11.11.3. The US Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 11.11.4. The US Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 11.11.5. Canada Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 11.11.6. Canada Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 11.11.7. Canada Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 11.11.8. Canada Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
• 12. Europe Radiopharmaceuticals Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
  • 12.3. Europe Radiopharmaceuticals Market Attractiveness Analysis, By Type
  • 12.4. Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
  • 12.5. Europe Radiopharmaceuticals Market Attractiveness Analysis, By Application
  • 12.6. Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
  • 12.7. Europe Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
  • 12.8. Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
  • 12.9. Europe Radiopharmaceuticals Market Attractiveness Analysis, By End-user
  • 12.10. Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 12.11. Europe Radiopharmaceuticals Market Attractiveness Analysis, By Country
    • 12.11.1. Germany Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.2. Germany Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.3. Germany Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.4. Germany Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.5. The U.K. Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.6. The U.K. Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.7. The U.K. Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.8. The U.K. Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.9. France Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.10. France Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.11. France Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.12. France Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.13. Spain Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.14. Spain Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.15. Spain Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.16. Spain Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.17. Italy Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.18. Italy Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.19. Italy Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.20. Italy Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.21. Russia & CIS Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.22. Russia & CIS Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.23. Russia & CIS Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.24. Russia & CIS Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 12.11.25. Rest of Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 12.11.26. Rest of Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 12.11.27. Rest of Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 12.11.28. Rest of Europe Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
• 13. Asia Pacific Radiopharmaceuticals Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
  • 13.3. Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Type
  • 13.4. Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
  • 13.5. Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Application
  • 13.6. Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
  • 13.7. Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
  • 13.8. Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
  • 13.9. Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By End-user
  • 13.10. Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 13.11. Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Country
    • 13.11.1. China Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.2. China Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.3. China Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.4. China Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.5. India Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.6. India Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.7. India Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.8. India Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.9. Japan Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.10. Japan Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.11. Japan Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.12. Japan Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.13. South Korea Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.14. South Korea Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.15. South Korea Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.16. South Korea Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.17. ASEAN Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.18. ASEAN Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.19. ASEAN Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.20. ASEAN Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.21. Australia & New Zealand Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.22. Australia & New Zealand Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.23. Australia & New Zealand Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.24. Australia & New Zealand Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 13.11.25. Rest of Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 13.11.26. Rest of Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 13.11.27. Rest of Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 13.11.28. Rest of Asia Pacific Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
• 14. Middle East & Africa Radiopharmaceuticals Market Analysis and Forecast, 2020-2035
  • 14.1. Key Findings
  • 14.2. Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
  • 14.3. Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Type
  • 14.4. Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
  • 14.5. Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Application
  • 14.6. Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
  • 14.7. Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
  • 14.8. Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
  • 14.9. Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By End-user
  • 14.10. Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 14.11. Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Country
    • 14.11.1. GCC Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 14.11.2. GCC Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 14.11.3. GCC Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 14.11.4. GCC Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 14.11.5. South Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 14.11.6. South Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 14.11.7. South Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 14.11.8. South Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 14.11.9. Rest of Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 14.11.10. Rest of Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 14.11.11. Rest of Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 14.11.12. Rest of Middle East & Africa Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
• 15. Latin America Radiopharmaceuticals Market Analysis and Forecast, 2020-2035
  • 15.1. Key Findings
  • 15.2. Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
  • 15.3. Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Type
  • 15.4. Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
  • 15.5. Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Application
  • 15.6. Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
  • 15.7. Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
  • 15.8. Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
  • 15.9. Latin America Radiopharmaceuticals Market Attractiveness Analysis, By End-user
  • 15.10. Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 15.11. Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Country
    • 15.11.1. Brazil Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 15.11.2. Brazil Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 15.11.3. Brazil Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 15.11.4. Brazil Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 15.11.5. Mexico Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 15.11.6. Mexico Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 15.11.7. Mexico Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 15.11.8. Mexico Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
    • 15.11.9. Rest of Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Type, 2020-2035
    • 15.11.10. Rest of Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Application, 2020-2035
    • 15.11.11. Rest of Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By Radioisotopes, 2020-2035
    • 15.11.12. Rest of Latin America Radiopharmaceuticals Market Size Value (US$ Bn) Forecast, By End-user, 2020-2035
• 16. Competitive Landscape & Company Profiles
  • 16.1. Market Competition Scenario Analysis, By Company
  • 16.2. Competitor Landscape
  • 16.3. Company Share Analysis
  • 16.4. Company Profiles
    • 16.4.1. Advanced Accelerator Applications
      • 16.4.1.1. Company Details
      • 16.4.1.2. Business Overview
      • 16.4.1.3. Portfolio
      • 16.4.1.4. Financial Insights
      • 16.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.1.6. SWOT Analysis
      • 16.4.1.7. Geographic Footprint
    • 16.4.2. Bayer AG
      • 16.4.2.1. Company Details
      • 16.4.2.2. Business Overview
      • 16.4.2.3. Portfolio
      • 16.4.2.4. Financial Insights
      • 16.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.2.6. SWOT Analysis
      • 16.4.2.7. Geographic Footprint
    • 16.4.3. Bracco Group
      • 16.4.3.1. Company Details
      • 16.4.3.2. Business Overview
      • 16.4.3.3. Portfolio
      • 16.4.3.4. Financial Insights
      • 16.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.3.6. SWOT Analysis
      • 16.4.3.7. Geographic Footprint
    • 16.4.4. Cardinal Health, Inc.
      • 16.4.4.1. Company Details
      • 16.4.4.2. Business Overview
      • 16.4.4.3. Portfolio
      • 16.4.4.4. Financial Insights
      • 16.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.4.6. SWOT Analysis
      • 16.4.4.7. Geographic Footprint
    • 16.4.5. Curium Pharma
      • 16.4.5.1. Company Details
      • 16.4.5.2. Business Overview
      • 16.4.5.3. Portfolio
      • 16.4.5.4. Financial Insights
      • 16.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.5.6. SWOT Analysis
      • 16.4.5.7. Geographic Footprint
    • 16.4.6. Eckert & Ziegler AG
      • 16.4.6.1. Company Details
      • 16.4.6.2. Business Overview
      • 16.4.6.3. Portfolio
      • 16.4.6.4. Financial Insights
      • 16.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.6.6. SWOT Analysis
      • 16.4.6.7. Geographic Footprint
    • 16.4.7. GE HealthCare Technologies Inc.
      • 16.4.7.1. Company Details
      • 16.4.7.2. Business Overview
      • 16.4.7.3. Portfolio
      • 16.4.7.4. Financial Insights
      • 16.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.7.6. SWOT Analysis
      • 16.4.7.7. Geographic Footprint
    • 16.4.8. ITM Isotopen Technologien München AG (ITM)
      • 16.4.8.1. Company Details
      • 16.4.8.2. Business Overview
      • 16.4.8.3. Portfolio
      • 16.4.8.4. Financial Insights
      • 16.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.8.6. SWOT Analysis
      • 16.4.8.7. Geographic Footprint
    • 16.4.9. Jubilant Radiopharma / Jubilant Pharmova Limited
      • 16.4.9.1. Company Details
      • 16.4.9.2. Business Overview
      • 16.4.9.3. Portfolio
      • 16.4.9.4. Financial Insights
      • 16.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.9.6. SWOT Analysis
      • 16.4.9.7. Geographic Footprint
    • 16.4.10. Lantheus Holdings, Inc.
      • 16.4.10.1. Company Details
      • 16.4.10.2. Business Overview
      • 16.4.10.3. Portfolio
      • 16.4.10.4. Financial Insights
      • 16.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.10.6. SWOT Analysis
      • 16.4.10.7. Geographic Footprint
    • 16.4.11. Mallinckrodt Pharmaceuticals
      • 16.4.11.1. Company Details
      • 16.4.11.2. Business Overview
      • 16.4.11.3. Portfolio
      • 16.4.11.4. Financial Insights
      • 16.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.11.6. SWOT Analysis
      • 16.4.11.7. Geographic Footprint
    • 16.4.12. Nordion Inc.
      • 16.4.12.1. Company Details
      • 16.4.12.2. Business Overview
      • 16.4.12.3. Portfolio
      • 16.4.12.4. Financial Insights
      • 16.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.12.6. SWOT Analysis
      • 16.4.12.7. Geographic Footprint
    • 16.4.13. Novartis AG
      • 16.4.13.1. Company Details
      • 16.4.13.2. Business Overview
      • 16.4.13.3. Portfolio
      • 16.4.13.4. Financial Insights
      • 16.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.13.6. SWOT Analysis
      • 16.4.13.7. Geographic Footprint
    • 16.4.14. Siemens Healthineers AG
      • 16.4.14.1. Company Details
      • 16.4.14.2. Business Overview
      • 16.4.14.3. Portfolio
      • 16.4.14.4. Financial Insights
      • 16.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.14.6. SWOT Analysis
      • 16.4.14.7. Geographic Footprint
    • 16.4.15. Telix Pharmaceuticals Limited
      • 16.4.15.1. Company Details
      • 16.4.15.2. Business Overview
      • 16.4.15.3. Portfolio
      • 16.4.15.4. Financial Insights
      • 16.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Development)
      • 16.4.15.6. SWOT Analysis
      • 16.4.15.7. Geographic Footprint

List of Tables

• Table 1: Global Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 2: Global Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 3: Global Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 4: Global Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 5: Global Radiopharmaceuticals Market Value (US$ Bn), By Region, 2020-2035
• Table 6: North America Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 7: North America Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 8: North America Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 9: North America Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 10: North America Radiopharmaceuticals Market Value (US$ Bn), By Country, 2020-2035
• Table 11: The US Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 12: The US Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 13: The US Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 14: The US Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 15: Canada Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 16: Canada Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 17: Canada Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 18: Canada Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 19: Europe Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 20: Europe Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 21: Europe Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 22: Europe Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 23: Europe Radiopharmaceuticals Market Value (US$ Bn), By Country, 2020-2035
• Table 24: Germany Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 25: Germany Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 26: Germany Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 27: Germany Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 28: The U.K. Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 29: The U.K. Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 30: The U.K. Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 31: The U.K. Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 32: France Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 33: France Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 34: France Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 35: France Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 36: Spain Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 37: Spain Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 38: Spain Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 39: Spain Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 40: Italy Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 41: Italy Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 42: Italy Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 43: Italy Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 44: Russia & CIS Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 45: Russia & CIS Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 46: Russia & CIS Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 47: Russia & CIS Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 48: Rest of Europe Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 49: Rest of Europe Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 50: Rest of Europe Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 51: Rest of Europe Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 52: Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 53: Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 54: Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 55: Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 56: Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Country, 2020-2035
• Table 57: China Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 58: China Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 59: China Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 60: China Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 61: India Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 62: India Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 63: India Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 64: India Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 65: Japan Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 66: Japan Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 67: Japan Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 68: Japan Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 69: South Korea Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 70: South Korea Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 71: South Korea Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 72: South Korea Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 73: ASEAN Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 74: ASEAN Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 75: ASEAN Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 76: ASEAN Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 77: Australia & New Zealand Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 78: Australia & New Zealand Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 79: Australia & New Zealand Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 80: Australia & New Zealand Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 81: Rest of Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 82: Rest of Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 83: Rest of Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 84: Rest of Asia Pacific Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 85: Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 86: Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 87: Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 88: Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 89: Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Country, 2020-2035
• Table 90: GCC Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 91: GCC Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 92: GCC Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 93: GCC Radiopharmaceuticals Market Value (US$ Bn),By End-user, 2020-2035
• Table 94: South Africa Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 95: South Africa Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 96: South Africa Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 97: South Africa Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 98: Rest of Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 99: Rest of Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 100: Rest of Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 101: Rest of Middle East & Africa Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 102: Latin America Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 103: Latin America Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 104: Latin America Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 105: Latin America Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 106: Latin America Radiopharmaceuticals Market Value (US$ Bn), By Country, 2020-2035
• Table 107: Brazil Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 108: Brazil Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 109: Brazil Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 110: Brazil Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 111: Mexico Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 112: Mexico Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 113: Mexico Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 114: Mexico Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035
• Table 115: Rest of Latin America Radiopharmaceuticals Market Value (US$ Bn), By Type, 2020-2035
• Table 116: Rest of Latin America Radiopharmaceuticals Market Value (US$ Bn), By Application, 2020-2035
• Table 117: Rest of Latin America Radiopharmaceuticals Market Value (US$ Bn), By Radioisotopes, 2020-2035
• Table 118: Rest of Latin America Radiopharmaceuticals Market Value (US$ Bn), By End-user, 2020-2035

List of Figures

• Figure 1: Global Radiopharmaceuticals Market Value (US$ Bn), 2020-2035
• Figure 2: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2025 & 2035
• Figure 3: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2025 & 2035
• Figure 4: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2025 & 2035
• Figure 5: Global Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2025 & 2035
• Figure 6: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 7: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 8: Global Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 9: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 10: Global Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 11: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 12: Global Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 13: Global Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 14: Global Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 15: Global Radiopharmaceuticals Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 16: Global Radiopharmaceuticals Market Attractiveness Analysis, By Region
• Figure 17: North America Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 18: North America Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 19: North America Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 20: North America Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 21: North America Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 22: North America Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 23: North America Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 24: North America Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 25: North America Radiopharmaceuticals Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 26: North America Radiopharmaceuticals Market Attractiveness Analysis, By Country
• Figure 27: Europe Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 28: Europe Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 29: Europe Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 30: Europe Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 31: Europe Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 32: Europe Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 33: Europe Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 34: Europe Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 35: Europe Radiopharmaceuticals Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 36: Europe Radiopharmaceuticals Market Attractiveness Analysis, By Country
• Figure 37: Asia Pacific Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 38: Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 39: Asia Pacific Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 40: Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 41: Asia Pacific Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 42: Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 43: Asia Pacific Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 44: Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 45: Asia Pacific Radiopharmaceuticals Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 46: Asia Pacific Radiopharmaceuticals Market Attractiveness Analysis, By Country
• Figure 47: Middle East & Africa Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 48: Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 49: Middle East & Africa Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 50: Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 51: Middle East & Africa Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 52: Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 53: Middle East & Africa Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 54: Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 55: Middle East & Africa Radiopharmaceuticals Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 56: Middle East & Africa Radiopharmaceuticals Market Attractiveness Analysis, By Country
• Figure 57: Latin America Radiopharmaceuticals Market Value Share (%) Analysis, By Type, 2020, 2025 and 2035
• Figure 58: Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Type
• Figure 59: Latin America Radiopharmaceuticals Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
• Figure 60: Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Application
• Figure 61: Latin America Radiopharmaceuticals Market Value Share (%) Analysis, By Radioisotopes, 2020, 2025 and 2035
• Figure 62: Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Radioisotopes
• Figure 63: Latin America Radiopharmaceuticals Market Value Share (%) Analysis, By End-user, 2020, 2025 and 2035
• Figure 64: Latin America Radiopharmaceuticals Market Attractiveness Analysis, By End-user
• Figure 65: Latin America Radiopharmaceuticals Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 66: Latin America Radiopharmaceuticals Market Attractiveness Analysis, By Country